Clinical trial
A Phase I Study of DN1406131 in Healthy Adults
NCT03641794 is registered in ClinicalTrials.gov with Jiangxi Qingfeng Pharmaceutical Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of DN1406131 in Healthy Adults
- Lead sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 7, 2018
- Completion date
- July 31, 2019
- Enrollment
- 56 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors